Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 6862

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.


Publication type: Journal Article

Larkin M.
Whose article is it anyway?
Lancet 1999 Jul 10; 354:(9173):136


Wyeth-Ayerst Laboratories, maker of the weight-loss drug dexfenfluramine, had paid ghost-writers for articles promotion obesity treatments and then used prominent researchers to publish the work in journals under their names.

*news story/United States/Wyeth/obesity/ghost-writing/ payment for writing articles/PROMOTION DISGUISED: GHOST-WRITING AND JOURNAL ARTICLES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: WEIGHT GAIN AND LOSS Authorship* Biomedical Research* Disclosure Drug Industry* Editorial Policies* Information Dissemination Peer Review, Research Periodicals Publishing/standards*


  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Click to Register

(read more)

Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend

As an advertising man, I can assure you that advertising which does not work does not continue to run. If experience did not show beyond doubt that the great majority of doctors are splendidly responsive to current [prescription drug] advertising, new techniques would be devised in short order. And if, indeed, candor, accuracy, scientific completeness, and a permanent ban on cartoons came to be essential for the successful promotion of [prescription] drugs, advertising would have no choice but to comply.
- Pierre R. Garai (advertising executive) 1963